1. Sato, Takashi, Soejima, Kenzo, Arai, Eri, Kanai, Yae, Betsuyaku, Tomoko. 2015. Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer. In Oncology reports, 34, 1137-45. doi:10.3892/or.2015.4082. https://pubmed.ncbi.nlm.nih.gov/26134684/
2. Chen, Aifeng, Ding, Shibiao, Shen, Xiaoqiang, Lin, Xuai. 2021. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma. In Computational and mathematical methods in medicine, 2021, 9932088. doi:10.1155/2021/9932088. https://pubmed.ncbi.nlm.nih.gov/34367321/
3. Bujko, Mateusz, Kober, Paulina, Statkiewicz, Małgorzata, Ostrowski, Jerzy, Siedlecki, Janusz Aleksander. 2017. Downregulation of PTPRH (Sap-1) in colorectal tumors. In International journal of oncology, 51, 841-850. doi:10.3892/ijo.2017.4068. https://pubmed.ncbi.nlm.nih.gov/28713969/
4. Jönsson, Jenny-Maria, Bartuma, Katarina, Dominguez-Valentin, Mev, Jönsson, Göran, Nilbert, Mef. . Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome. In Familial cancer, 13, 537-45. doi:10.1007/s10689-014-9728-1. https://pubmed.ncbi.nlm.nih.gov/24848881/
5. Wälchli, Sébastien, Espanel, Xavier, Hooft van Huijsduijnen, Rob. . Sap-1/PTPRH activity is regulated by reversible dimerization. In Biochemical and biophysical research communications, 331, 497-502. doi:. https://pubmed.ncbi.nlm.nih.gov/15850787/